Table 5. Classification of HRCT scans after radiotherapy in the overall study population (N = 37), as well as in patients who underwent supraclavicular lymph node irradiation and those who did not, according to the scoring system by Schratter-Sehn et al. 6 ), a .
| HRCT scan score | Overall | SCLN irradiation | |
|---|---|---|---|
| No (n = 17) | Yes (n = 20) | ||
| 0 | 5 (13.5%) | 3 (17.7%) | 2 (10%) |
| 1 | 17 (45.9%) | 9 (52.9%) | 8 (40%) |
| 2 | 8 (21.6%) | 3 (17.6%) | 5 (25%) |
| 3 | 5 (13.5%) | 2 (11.8%) | 3 (15%) |
| 4 | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
| 5 | 2 (5.4%) | 0 (0.0%) | 2 (10%) |
SCLN: supraclavicular lymph node. aScore: 0 = no changes; 1 = septal thickening, reticular subpleural opacities; 2 = subpleural thickening > 2 cm parallel to the chest wall; 3 = parenchymal bands ≥ 2.5 cm from the lung toward the pleural surface; 4 = honeycombing aspect, cystic areas (> 1 cm diameter), thickened walls; 5 = ground glass opacities, acute radiological changes.